MATTHEW ANDERSON: Open Payments
NPI 1144733544 · EL CAJON, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 81 payments from 16 companies in 2025. Trend: 2023 $810 · 2024 $1,469 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 47 | $632 |
| ViiV Healthcare Company | 6 | $131 |
| Novo Nordisk Inc | 6 | $130 |
| Hologic Sales and Service, LLC | 3 | $76 |
| PFIZER INC. | 3 | $56 |
| ABBVIE INC. | 3 | $55 |
| Lilly USA, LLC | 3 | $53 |
| Cipher Pharmaceuticals US LLC | 1 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
Products named: APTIMA, DOVATO, APRETUDE, Natroba, Biktarvy, MOUNJARO, ELIQUIS, BREZTRI.
Industry payments across CA — which companies pay providers there.
